The factors driving the proliferation of lymphatic vessels in patients with GSD or GLA are not known but may include known lymphangiogenic cytokines such as vascular endothelial growth factor (VEGF)-A, VEGF-C, VEGF-D and platelet-derived growth factor (PDGF)-BB [18]. This evidence concerns the gene VEGFA and diffuse lymphatic malformation.